MANHATTAN SCIENTIFICS INC Quarterly Debt-to-equity in % from Q3 2012 to Q2 2024

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Manhattan Scientifics Inc quarterly Debt-to-equity history and growth rate from Q3 2012 to Q2 2024.
  • Manhattan Scientifics Inc Debt-to-equity for the quarter ending June 30, 2024 was -72.6 %, a 21.4% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q2 2024 -72.6 +19.7 +21.4% Jun 30, 2024
Q1 2024 -74.5 +29 +28.1% Mar 31, 2024
Q4 2023 -77.6 +85.4 +52.4% Dec 31, 2023
Q3 2023 -82.8 +456 +84.6% Sep 30, 2023
Q2 2023 -92.3 -543 -120% Jun 30, 2023
Q1 2023 -103 -219 -190% Mar 31, 2023
Q4 2022 -163 -220 -386% Dec 31, 2022
Q3 2022 -538 -577 -1486% Sep 30, 2022
Q2 2022 451 +402 +824% Jun 30, 2022
Q1 2022 115 +35.9 +45.2% Mar 31, 2022
Q4 2021 57 -293 -83.7% Dec 31, 2021
Q3 2021 38.8 +309 Sep 30, 2021
Q2 2021 48.8 +276 Jun 30, 2021
Q1 2021 79.3 +302 Mar 31, 2021
Q4 2020 350 +658 Dec 31, 2020
Q3 2020 -270 +164 +37.7% Sep 30, 2020
Q2 2020 -227 -693 -149% Jun 30, 2020
Q1 2020 -223 -349 -276% Mar 31, 2020
Q4 2019 -308 -369 -609% Dec 31, 2019
Q3 2019 -434 -469 -1345% Sep 30, 2019
Q2 2019 466 +443 +1952% Jun 30, 2019
Q1 2019 127 +111 +713% Mar 31, 2019
Q4 2018 60.5 +44.9 +287% Dec 31, 2018
Q3 2018 34.8 +10.7 +44.5% Sep 30, 2018
Q2 2018 22.7 -18.6 -45% Jun 30, 2018
Q1 2018 15.6 -53.7 -77.5% Mar 31, 2018
Q4 2017 15.7 -67.6 -81.2% Dec 31, 2017
Q3 2017 24.1 -35.8 -59.8% Sep 30, 2017
Q2 2017 41.3 -2.06 -4.75% Jun 30, 2017
Q1 2017 69.2 +33.4 +93.4% Mar 31, 2017
Q4 2016 83.2 +52.4 +170% Dec 31, 2016
Q3 2016 59.9 +19.9 +49.7% Sep 30, 2016
Q2 2016 43.4 -21.6 -33.2% Jun 30, 2016
Q1 2016 35.8 -131 -78.5% Mar 31, 2016
Q4 2015 30.9 +258 Dec 31, 2015
Q3 2015 40 +220 Sep 30, 2015
Q2 2015 65 +259 Jun 30, 2015
Q1 2015 167 +377 Mar 31, 2015
Q4 2014 -227 -2.48 -1.11% Dec 31, 2014
Q3 2014 -180 +107 +37.2% Sep 30, 2014
Q2 2014 -194 +158 +44.9% Jun 30, 2014
Q1 2014 -211 +182 +46.4% Mar 31, 2014
Q4 2013 -224 +248 +52.6% Dec 31, 2013
Q3 2013 -287 +419 +59.4% Sep 30, 2013
Q2 2013 -351 Jun 30, 2013
Q1 2013 -393 Mar 31, 2013
Q4 2012 -473 Dec 31, 2012
Q3 2012 -705 Sep 30, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.